Union biometrics유니온바이오메트릭스
203450 · KOSDAQ · ₩203450 · 유니온바이오메트릭스
What brokers say about Union biometrics
Calculated by JONBUR from publicly available broker reports. Reports belong to their publishers. Not financial advice. Includes brokers that publish research publicly; some brokers' reports are client-only and not included.
AI summary of public information
An AI summary of the public information on this company: filed financial statements, filings, prices and news headlines. It doesn't use broker reports; their targets and estimates are shown above.
Union Biometrics is loss-making at the operating line over the last twelve months, though its share price has fallen and its shares trade at about 0.9 times book value.
Union Biometrics, a KOSDAQ-listed maker of fingerprint, face and iris access control devices, reported trailing twelve-month revenue of about ₩51.9B to H1 2026 with an operating loss of about ₩0.7B and a small net profit of about ₩1.2B. Revenue has fallen from its 2024 peak of ₩56.7B, and the shares are down 15.5% over one year, trading near the lower part of their 52-week range. The data does not give a clear reason for the swing from 2024 profits to the current trailing loss.
What stands out
- Trailing operating margin is -1.3%, down from 5.0% in 2024, while the net result is positive at about ₩1.2B, likely helped by non-operating items the data does not break down.
- Trailing free cash flow is about -₩3.4B and cash of ₩4.3B sits against borrowings of ₩9.5B, so debt is larger than cash in the data provided.
- Recent filings include a major sales or supply contract dated 6 October 2026, and a news report on 15 October 2026 links the CEO's purchase of 40,000 treasury shares to record orders.
- The market value is about ₩36.2B and the price-to-book ratio is 0.9, while the trailing price-to-earnings ratio is 29.4 on the filed earnings.
- Insider shareholding reports and an amended report were filed in October 2026, and foreign ownership is little changed at 8.6%.
What to watch
- The full-year 2026 results and the terms of the recent supply contract, which the data does not describe in detail.
- Whether operating income returns to a sustained profit, given the trailing operating loss and falling revenue.
- Debt levels versus cash and the negative free cash flow, which the data shows but does not explain.
Data as of Oct 23, 2026 · written 4d ago
This is not financial advice.
Also known as: Union biometrics / 유니온바이오메트릭스 / 203450 / KRX:203450
Source: KRX statistical information